Biosphere Hopes CMS Decision Will Influence Third Party Payers
Effective January 1, 2008, the Centers for Medicare and Medicaid Services (CMS) will increase its hospital outpatient reimbursement for uterine fibroid embolization (UFE) by 113 […]
Articles by Doug Cress
New Venues Open to Chembio Clearview
Chembio Diagnostics has received a CLIA Waiver for its FDA-approved HIV Barrel test – a self contained rapid HIV test that is marketed worldwide by […]
Distribution Agreements Put AMDL’s New Beauty Product Line on Firm Footing
Jade Pharmaceutical Inc. a wholly owned subsidiary of AMDL, Inc., disclosed new regional distribution agreements for its Goodnak anti-aging and skin care injectable product line. […]
Five New Needle-Free Delivery Devices
Despite physicians’ best efforts and parents’ reassurance, receiving a shot is a terrifying experience for a young child. And with an ever-increasing population of insulin-dependent […]
Consumer Demand Drives Aesthetic Market
Nearly five centuries after Ponce de León failed to locate the Fountain of Youth, medical technology has advanced to a stage where willing-and-able consumers can […]
PhotoMedex Eyes Lashes
PhotoMedex, a Montgomeryville, PA, company best known for its XTRAC laser system for treating psoriasis, is out with a new product that’s more high fashion […]
Diagnostics Firm Acquires Rights to Schizophrenia Data
Nanogen, a San Diego-based diagnostics firm, has acquired the rights to genetic markers related to schizophrenia and responses to antipsychotic therapies — an important step […]
FDA Panel to Review Device that Prevents Scar Tissue
SyntheMed, of Iselin, NJ, today got word that an FDA panel will advance the first anti-adhesion product in what the company estimates is a $2 […]
Amended Agreement Expands Cambridge Heart’s Reach
Cambridge Heart, of Bedford, MA, has amended its marketing agreement with St. Jude Medical in a way that could significantly expand access to tests for […]
Seeking Partners for Melanoma-Detection Device
With its final pivotal trial moving along as planned, Irvington, NY-based Electro-Optical Sciences is actively initiating partnering discussions for its point-of-case melanoma-detection device. MelaFind is […]